Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
Nanotoxicology. 2011 Dec;5(4):459-68. doi: 10.3109/17435390.2010.516026. Epub 2010 Sep 21.
There is a paucity of data regarding the safety of administering solid gold nanoparticles (AuNPs) in large animal tumor models. We assessed the acute toxicity and biodistribution of 5 nm and 25 nm solid AuNPs in New Zealand White rabbits (n = 6 in each) with implanted liver Vx2 tumors 24 h after intravenous injection. Gold concentration was determined by inductively coupled plasma atomic emission spectrometry (ICP) and imaged with transmission electron microscopy (TEM). There was no clinico-pathologic evidence of renal, hepatic, pulmonary, or other organ dysfunction. After 25 nm AuNP administration, the concentration of white blood cells increased after treatment (p = 0.001). Most other blood studies were unchanged. AuNPs were distributed to the spleen, liver, and Vx2 tumors, but not to other tissues. The urinary excretion of AuNPs was bimodal as measured by ICP. 25 nm AuNPs were more evenly distributed throughout tissues and may be better tools for medical therapy.
关于在大型动物肿瘤模型中给予固态金纳米粒子(AuNPs)的安全性的数据很少。我们评估了 5nm 和 25nm 固态 AuNPs 在新西兰白兔(每组 6 只)中的急性毒性和生物分布,这些白兔在静脉注射 24 小时后植入了肝脏 Vx2 肿瘤。金浓度通过电感耦合等离子体原子发射光谱法(ICP)测定,并通过透射电子显微镜(TEM)成像。没有肾、肝、肺或其他器官功能障碍的临床病理证据。在给予 25nm AuNP 后,白细胞浓度在治疗后增加(p=0.001)。大多数其他血液研究没有变化。AuNPs 分布于脾脏、肝脏和 Vx2 肿瘤,但不分布于其他组织。通过 ICP 测量,AuNPs 的尿排泄呈双峰模式。25nm AuNPs 在组织中的分布更加均匀,可能是更好的医疗治疗工具。